For the first time, the U.S. Food and Drug Administration has authorized for emergency use a breath test to detect COVID-19.
The InspectIR COVID-19 Breathalyzer is the “size of a piece of carry-on luggage” and can analyze chemical compounds in breath samples to test for COVID-19, the FDA states.
Samples can be collected and analyzed in the same place in less than three minutes, which enables it to be carried out in places such as doctor’s offices, hospitals, and mobile testing sites.
The test uses gas chromatography gas mass-spectrometry (GC-MS) to isolate different chemical mixtures and quickly detect certain compounds—referred to as Volatile Organic Compounds (VOCs)—associated with COVID-19 infection in the breath samples.